Ocular Therapeutix joins Baird Global Healthcare Conference fireside chat
OCUL•Conference appearances and trial presentation schedule
- Ocular Therapeutix will hold investor one-on-one meetings at the Wells Fargo 21st Annual Healthcare Conference on Sept. 10, 2026.
- A fireside chat is scheduled at the Baird 2026 Global Healthcare Conference on Sept. 15, 2026, 10:50-11:20 a.m. EDT.
- Phase 3 SOL-1 data on OTX-TKI in wet AMD will be presented at Retina Society on Sept. 24, 2026.
- The same SOL-1 results are slated for Euretina Congress on Oct. 2, 2026, 13:24-13:30 CEST.




